THE ESCAPE ROOM FOR CARDIORESPIRATORY ARREST CARE IN PRIMARY HEALTH CARE

November 12, 2026 updated by: Mariana Dolce Marques, University of Campinas, Brazil

This is a randomized controlled trial. The study population consists of a minimum of 162 Primary Health Care professionals. The sample includes physicians, nurses, nursing technicians, and nursing assistants involved in direct patient care at selected Primary Health Care Units who agree to participate in the study.

The Primary Health Care Units were stratified according to size and randomly allocated into two groups. Health professionals from these units were invited to participate either in the intervention group (n=81) or the control group (n=81). Participants in the intervention group will receive escape room-based training, whereas participants in the control group will receive traditional training through a dialogic lecture. Due to the nature of the intervention, neither participants nor the principal investigator will be blinded.

Both groups will be assessed regarding Basic Life Support (BLS) knowledge and Cardiopulmonary Resuscitation (CPR) skills at three time points: baseline before training (T0), immediately after training (T1), and 15 days after training (T2).

Objective - To evaluate whether escape room-based training for the management of cardiopulmonary arrest (CPA) among Primary Health Care professionals is effective in improving the retention of CPR knowledge and skills when compared with traditional dialogic lecture-based training.

Study Overview

Status

Enrolling by invitation

Conditions

Intervention / Treatment

Detailed Description

The municipality has 69 Primary Health Care Units, comprising a total of 240 registered healthcare teams. These teams include general practitioners or Family Health specialists, nurses with generalist or Family Health specialization, nursing assistants or technicians, and Community Health Workers.

Sample size was initially calculated based on the objective of comparing the two groups at the final assessment time point according to chest compression performance measured by a feedback application. The calculation was based on Pearson's Chi-square test methodology, assuming a significance level of 1.0% and a statistical power of 80%. The significance level was adjusted using the Bonferroni correction according to the number of comparisons between groups and assessment periods. An effect size of 0.30 was assumed, which is considered a medium effect size according to Cohen (1992). The resulting sample size was 130 participants (65 per group).

Sample size was also calculated considering the objective of comparing the two groups across the three assessment periods according to knowledge scores. For this calculation, a repeated-measures ANOVA model was used, assuming a significance level of 5%, statistical power of 80%, and an effect size of 0.25, considered a medium effect size. This calculation resulted in a minimum sample of 86 participants (43 per group).

Based on these calculations, a minimum sample size of 130 participants was established. An additional 20% was included to account for potential losses to follow-up, resulting in a final sample size of 162 participants (81 per group). Sample size calculations were performed using G*Power version 3.1.9.7 and PASS version 13.

The sample was stratified within each group according to unit size (small, medium, or large). Each group included 81 participants, resulting in 27 participants per stratum. Within each stratum, simple random sampling was applied to select the units (clusters) allocated to each group and determine the data collection sequence. This process was conducted by an independent statistician who was not part of the primary research team, using R Project version 4.3.3.

The principal investigator will contact the managers of the selected units according to randomization allocation and invite them to participate in the study. After acceptance and scheduling, healthcare professionals from the respective units will be invited to participate. Data collection will take place at the healthcare units during participants' working hours. Participants will undergo the educational intervention (control or intervention) in two sessions separated by a 15-day interval.

Participant data will be collected using Research Electronic Data Capture (REDCap). The following assessment measures will be used throughout the study:

  • Sociodemographic and professional experience questionnaire (T0);
  • Theoretical knowledge test (T0, T1, and T2);
  • CPR skills assessment (T0, T1, and T2) for both Control Group (CG) and Intervention Group (IG).

Participants in the Intervention Group will additionally complete:

  • Student Satisfaction and Self-Confidence in Learning Scale (T1);
  • Brazilian version of the Simulation Effectiveness Tool - Modified (SET-M) (T1). Both questionnaires will be administered after participation in the escape room educational activity.

Dependent Variables:

  • Knowledge Test: Number of correct answers on a multiple-choice questionnaire (quantitative variable).
  • Skills Test: Performance of 2 minutes of CPR involving chest compressions on a low-fidelity manikin equipped with a feedback application that evaluates compression rate, depth, and chest recoil during CPR associated with bag-valve-mask ventilation. Adequate compression depth will be defined as 5-6 cm. Adequate compression rate will be 100-120 compressions per minute. Adequate chest recoil will be defined as residual leaning of ≤5 mm throughout all compressions. Ventilation will be considered adequate when sufficient volume produces visible chest rise. Performance will be assessed using a Resusci Anne® adult simulator (Laerdal®, Stavanger, Norway) connected via Bluetooth to the QCPR (Quality CPR) application (Laerdal®, Stavanger, Norway), in addition to a training Automated External Defibrillator (AED) (Laerdal®).

High-quality CPR will be defined as maintenance of all compression and ventilation criteria throughout the 2-minute assessment period (categorical variable).

Independent Variables

  • Sociodemographic characteristics and professional experience;
  • Previous training history;
  • Satisfaction with learning, self-confidence in learning, and simulation effectiveness (intervention group only).

Study Type

Interventional

Enrollment (Estimated)

162

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • São Paulo
      • Campinas, São Paulo, Brazil
        • School of Nursing - Campinas University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Healthcare professionals working in Family Health Strategy (FHS) teams at Primary Health Care Units capable of providing urgent and emergency care.
  • Professionals registered with their respective professional regulatory councils.

Exclusion Criteria:

  • Healthcare professionals with restrictions preventing them from performing emergency care activities, such as physical disabilities that impair execution of CPR maneuvers.
  • Professionals on leave or absent from work during the recruitment period corresponding to the selection of their workplace for study participation.

Loss to Follow-up:

Participants will be considered lost to follow-up (missing data) if, after completing the first data collection assessment, they take any type of leave from work or fail to attend the second scheduled data collection session.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Interventional group

Participants will be welcomed in a designated room within the Primary Health Care Unit. The nature of the research will be explained, and written informed consent will be obtained.

Participants who agree to participate will receive audiovisual training on cardiopulmonary arrest management through a clinical simulation set in a Primary Health Care environment. Subsequently, they will participate in an escape room activity conducted in the unit's emergency room setting. Four participants will act as active volunteers in the scenario, while the remaining participants will serve as observers. The activity includes pre-briefing, briefing, and scenario execution.

The escape room consists of seven puzzles and three additional puzzles facilitated by the game master (the principal investigator), all related to adult Basic Life Support management.

Following completion of the escape room activity, all participants will take part in a structured debriefing session.

Audiovisual and Escape room practice training for CPR for health professionals.

No Intervention: Control Group

Participants will be welcomed in a designated room within the Primary Health Care Unit. The nature of the research will be explained, and written informed consent will be obtained.

Participants who agree to participate will receive traditional training in cardiopulmonary arrest management through a dialogic lecture.

Traditional education will consist of narration, question-and-answer interactions, and discussion techniques using a PowerPoint presentation containing both visual and textual educational content delivered in a classroom environment.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Knowledge Test
Time Frame: Baseline before training (T0), immediately after training (T1), and 15 days after training (T2).

Number of correct answers on a multiple-choice questionnaire (quantitative variable).

Baseline before training (T0), immediately after training (T1), and 15 days after training (T2).
Skills Test
Time Frame: Baseline before training (T0), immediately after training (T1), and 15 days after training (T2).

Performance of 2 minutes of CPR involving chest compressions on a low-fidelity manikin equipped with a feedback application that evaluates compression rate, depth, and chest recoil during CPR associated with bag-valve-mask ventilation.

Adequate compression depth will be defined as 5-6 cm. Adequate compression rate will be 100-120 compressions per minute. Adequate chest recoil will be defined as residual leaning of ≤5 mm throughout all compressions. Ventilation will be considered adequate when sufficient volume produces visible chest rise.

Performance will be assessed using a Resusci Anne® adult simulator (Laerdal®, Stavanger, Norway) connected via Bluetooth to the QCPR (Quality CPR) application (Laerdal®, Stavanger, Norway), in addition to a training Automated External Defibrillator (AED) (Laerdal®).

High-quality CPR will be defined as maintenance of all compression and ventilation criteria throughout the 2-minute assessment period (categorical variable).

Baseline before training (T0), immediately after training (T1), and 15 days after training (T2).

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sociodemographic characteristics and professional experience
Time Frame: Baseline before training (T0)

Sex, age, professional category, experience in primary health care, experience in critical health care.

Baseline before training (T0)
Previous training history
Time Frame: Baseline before training (T0)

Experience in BLS, ACLS and first aid training

Baseline before training (T0)
Satisfaction with learning, self-confidence in learning, and simulation effectiveness (intervention group only).
Time Frame: immediately after training (T1)

Use the Student Satisfaction and Self-Confidence in Learning Scale and Brazilian version of the Simulation Effectiveness Tool - Modified (SET-M).

immediately after training (T1)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 9, 2026

Primary Completion (Actual)

August 13, 2026

Study Completion (Estimated)

December 1, 2026

Study Registration Dates

First Submitted

November 12, 2026

First Submitted That Met QC Criteria

November 12, 2026

First Posted (Actual)

November 18, 2026

Study Record Updates

Last Update Posted (Actual)

November 18, 2026

Last Update Submitted That Met QC Criteria

November 12, 2026

Last Verified

November 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 88362825.6.0000.5404
  • Financial Code 001 (Other Identifier: Coordenação Aperfeiçoamento Pessoal de Nível Superior Brasil (CAPES))

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

The research data will be made available on UNICAMP's REDU, which is the university's official platform for depositing, preserving, sharing, reusing, and reproducing research data generated at the university

IPD Sharing Time Frame

The data will be published at the end of the research, expected in December 2027

IPD Sharing Access Criteria

Open access

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.